| Name | Title | Contact Details |
|---|
Founded in 2004, Direct Flow Medical®, Inc. is focused on developing novel transcatheter heart valve technologies that improve patient outcomes while reducing patient complications. The company is exploring application of its proprietary technology beyond the aortic valve, to the mitral valve and other valve anatomy. Headquartered in Santa Rosa, California, the company also has technology and manufacturing facilities in Lake Forest, California. The Direct Flow Medical TAVI system received the CE Mark in January 2013 and is currently available commercially in Europe. Company Culture: Direct Flow Medical, Inc. has a very unique corporate culture and has developed a set of principles that makes this a unique place to work. Our company is a community, and people feel best when they are proud of their community and know that it is accomplishing something worthwhile. Our employees are encouraged to get to know one another and to support one another in their achievements. We acknowledge and celebrate professional goals as well as personal milestones. The atmosphere at Direct Flow Medical, Inc. is one that supports both a sense of satisfaction from our work, and also a sense of companionship with our co-workers.
Achieve your health and wellness goals with our customized, expertly-formulated nutritional supplements and vitamins. Try WellPath today!
PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.
Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.
Southwest Mississippi Regional Medical Center (SMRMC) in McComb, Mississippi was established in 1969, and serves a seven-county area of Mississippi. SMRMC also draws from two parishes in neighboring eastern Louisiana. According to the most recent